Traceability systems offer the technical possibility to trace medical products along
the supply chain – from final stage manufacture to the ultimate place where the
medical product is administered to an individual – with a view to strengthening the
near real-time monitoring of the integrity of product. There is global recognition
that traceability systems can be leveraged as useful tools to ensure the integrity and
improve the efficiency of supply chains. Traceability may not be able to completely
block falsified medical products from entering the supply chain but implemented
alongside the considerations contained in this policy paper, it can minimize the risk
and allow for earlier detection and response